Erythema - 149 Studies Found
| Completed |
: Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions : Discoid Lupus Erythematosus : 2008-02-20 :
|
| Completed |
: Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus : Discoid Lupus Erythematosus : 2008-01-23 :
|
| Terminated |
: Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva : Discoid Lupus Erthematosus of the Scalp. : 2006-03-28 : Drug: Raptiva (efalizumab) |
| Completed |
: A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus : Discoid Lupus Erythematosus : 1999-11-03 : Drug: Thalidomide |
| Completed |
: Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) : Discoid Lupus Erythematosus : 2008-02-20 :
|
| Completed |
: The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus : Discoid Lupus Erythematosus (DLE) : 2008-11-21 : Drug: etanercept(Enbrel®) etanercept(Enbrel®) 50mgs subcutaneous (SC) injections twice weekly |
| Recruiting |
: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus :
|
| Recruiting |
: Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) :
: 2017-05-02 : Biological: Tofacitinib citrate 10 mg daily by mouth |
| Completed |
: A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies : Lupus Erythematosus, Discoid : 2012-12-19 :
|
| Completed |
: Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients : Discoid Lupus Erythematosus : 2008-07-01 : Drug: CC-10004 20 mg twice daily by mouth for 12 weeks, followed by a 4 week washout period and final as |